KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Crescent Capital BDC (CCAP) EPS (Weighted Average and Diluted) (2021 - 2025)

Historic EPS (Weighted Average and Diluted) for Crescent Capital BDC (CCAP) over the last 5 years, with Q3 2025 value amounting to $0.46.

  • Crescent Capital BDC's EPS (Weighted Average and Diluted) fell 2812.5% to $0.46 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.92, marking a year-over-year decrease of 2258.06%. This contributed to the annual value of $2.44 for FY2024, which is 609.03% up from last year.
  • As of Q3 2025, Crescent Capital BDC's EPS (Weighted Average and Diluted) stood at $0.46, which was down 2812.5% from $0.46 recorded in Q2 2025.
  • Crescent Capital BDC's EPS (Weighted Average and Diluted)'s 5-year high stood at $0.64 during Q3 2024, with a 5-year trough of $0.39 in Q1 2022.
  • Its 5-year average for EPS (Weighted Average and Diluted) is $0.52, with a median of $0.52 in 2022.
  • Per our database at Business Quant, Crescent Capital BDC's EPS (Weighted Average and Diluted) surged by 3846.15% in 2023 and then tumbled by 2857.14% in 2025.
  • Quarter analysis of 5 years shows Crescent Capital BDC's EPS (Weighted Average and Diluted) stood at $0.42 in 2021, then grew by 23.81% to $0.52 in 2022, then increased by 19.23% to $0.62 in 2023, then decreased by 10.47% to $0.56 in 2024, then dropped by 17.13% to $0.46 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.46 in Q3 2025, compared to $0.46 in Q2 2025 and $0.45 in Q1 2025.